DoW Vision, Investigator-Initiated Research Award
- Response deadline
- Nov 12, 2026 Due in 31 days
- Date posted
- May 5, 2026
- Source
- Open notice
Description
Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Investigator-Initiated Research Award (IIRA) supports basic through early translational research that will yield highly impactful discoveries or major advancements in the research and/or patient care of eye injury and/or visual dysfunction related to military exposure . The IIRA may be used to support preclinical studies and/or clinical research . Research must align with at least one of the FY26 VRP Focus Areas . The IIRA cannot be used to support clinical trials . Distinctive Features: · The IIRA offers two Funding Levels to support research at different stages and the exploration/development of ideas of different maturity levels. · Funding Level 2 includes a Partnering Principal Investigator (PI) Option (PPIO) for two PIs, an Initiating PI and a Partnering PI. · Scored peer review criteria include Research Idea/Rationale, Research Strategy and Feasibility, Impact, and Personnel. · Programmatic review criteria include adherence to the intent of the IIRA, contribution to the VRP portfolio, relative impact, and relevance to military health. · The VRP may share FY26 IIRA applications and reviews with the National Eye Institute (NEI) for independent funding consideration. https://cdmrp.health.mil/pubs/press/2026/vrppreann
Classifications
- NAICS12.420
Documents (2)
Contacts
- help@ebrap.org301-619-1139
Similar contracts
- DoW Breast Cancer, Breakthrough Award Levels 1 and 2Due Nov 18, 2026
- DoW Breast Cancer, Clinical Research Extension AwardDue Nov 18, 2026
- DoW Reconstructive Transplant, Investigator-Initiated Research AwardDue Nov 4, 2026
- DoW Neurofibromatosis Research Academy – Scholar AwardDue Sep 22, 2026
- DoW Neurofibromatosis Investigator-Initiated Research AwardDue Sep 22, 2026
- DoW Neurofibromatosis Exploration-Hypothesis Development AwardDue Sep 22, 2026